Phát hiện tiêm EPO bằng phương pháp thử nghiệm isoform nhanh kiểu dòng chảy ngang

Lundby C, Robach P, Saltin B (2012) The evolving science of detection of 'blood doping'. Br J Pharmacol 165(5):1306–1315 Barroso O, Mazzoni I, Rabin O (2008) Hormone abuse in sports: the antidoping perspective. Asian J Androl 10(3):391–402 Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA (2008) Does recombinant human EPO increase exercise capacity by means other than augmenting oxygen transport? J Appl Physiol 105(2):581–587 Halstenson CE, Macres M, Katz SA, Schnieders JR, Watanabe M, Sobota JT, Abraham PA (1991) Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther 50(6):702–712 Dou P, Liu Z, He J, Xu JJ, Chen HY (2008) Rapid and high-resolution glycoform profiling of recombinant human erythropoietin by capillary isoelectric focusing with whole column imaging detection. J Chromatogr 1190(1–2):372–376 Wang H, Dou P, Lu C, Liu Z (2012) Immuno-magnetic beads-based extraction-capillary zone electrophoresis-deep UV laser-induced fluorescence analysis of erythropoietin. J Chromatogr 1246:48–54 Wide L, Bengtsson C (1990) Molecular charge heterogeneity of human serum erythropoietin. Br J Haematol 76(1):121–127 Wide L, Bengtsson C, Berglund B, Ekblom B (1995) Detection in blood and urine of recombinant erythropoietin administered to healthy men. Med Sci Sports Exerc 27(11):1569–1576 Lasne F, Martin L, Crepin N, de Ceaurriz J (2002) Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 311(2):119–126 Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W (2008) Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int J Sports Med 29(01):1–6 Reichel C, Kulovics R, Jordan V, Watzinger M, Geisendorfer T (2009) SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Drug Test Anal 1(1):43–50 Franco Fraguas L, Carlsson J, Lönnberg M (2008) Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins. J Chromatogr 1212(1–2):82–88 Lönnberg M, Andren M, Birgegard G, Drevin M, Garle M, Carlsson J (2012) Rapid detection of erythropoiesis-stimulating agents in urine and serum. Anal Biochem 420:101–114 Reichel C (2011) Recent developments in doping testing for erythropoietin. Anal Bioanal Chem 401(2):463–481 Dehnes Y, Lamon S, Lonnberg M (2010) Erythropoietin (EPO) immunoaffinity columns—a powerful tool for purifying EPO and its recombinant analogues. J Pharm Biomed Anal 53(4):1028–1032 Lönnberg M, Dehnes Y, Drevin M, Garle M, Lamon S, Leuenberger N, Quach T, Carlsson J (2010) Rapid affinity purification of erythropoietin from biological samples using disposable monoliths. J Chromatogr 1217(45):7031–7037 Lonnberg M, Bondesson U, Cormant F, Garcia P, Bonnaire Y, Carlsson J, Popot MA, Rollborn N, Rasbo K, Bailly-Chouriberry L (2012) Detection of recombinant human EPO administered to horses using MAIIA lateral flow isoform test. Anal Bioanal Chem 403(6):1619–1628 Ashenden M, Sharpe K, Garnham A, Gore CJ (2012) Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma. J Pharm Biomed Anal 67–68:123–128 Lundby C, Achman-Andersen NJ, Thomsen JJ, Norgaard AM, Robach P (2008) Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing. J Appl Physiol 105(2):417–419 Lasne F, Martin L, Martin JA, de Ceaurriz J (2007) Isoelectric profiles of human erythropoietin are different in serum and urine. Int J Biol Macromol 41(3):354–357 Lamon S, Robinson N, Sottas P-E, Henry H, Kamber M, Mangin P, Saugy M (2007) Possible origins of undetectable EPO in urine samples. Clin Chim Acta 385(1–2):61–66 Lamon S, Martin L, Robinson N, Saugy M, Ceaurriz J, Lasne F (2009) Effects of exercise on the isoelectric patterns of erythropoietin. Clin J Sport Med 19(4):311–315 Beullens M, Delanghe JR, Bollen M (2006) False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood 107(12):4711–4713 Jelkmann W (2007) Novel erythropoietic agents: a threat to sportsmanship. Medicina Sportiva 11(2):32–42 Lönnberg M, Drevin M, Carlsson J (2008) Ultra-sensitive immunochromatographic assay for quantitative determination of erythropoietin. J Immunol Methods 339(2):236–244 Zorzoli M (2005) Blood monitoring in anti-doping setting. Recent Adv Doping Anal 13:255–264 Sharpe K, Ashenden MJ, Schumacher YO (2006) A third generation approach to detect erythropoietin abuse in athletes. Haematologica 91(3):356–363 Borno A, Aachmann-Andersen NJ, Munch-Andersen T, Hulston CJ, Lundby C (2010) Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport. Eur J Appl Physiol 109(3):537–543 Franz SE (2009) Erythropoiesis-stimulating agents: development, detection and dangers. Drug Test Anal 1(6):245–249 Macdougall IC, Ashenden M (2009) Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications. Adv Chronic Kidney Dis 16(2):117–130 Dehnes Y, Hemmersbach P (2011) Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera) and epoetin delta (Dynepo) on isoelectric erythropoietin profiles and haematological parameters. Drug Test Anal 3(5):291–299